Table 1.
Characteristics of study populations.
| Characteristics | Convalescents | Vaccinated | p | Control group |
|---|---|---|---|---|
| Total N (%) | 71 (100) | 75 (100) | 18 (100) | |
| Gender | 0.83 | |||
| Male N (%) | 23 (32) | 22 (29) | 7 (39) | |
| Female N (%) | 48 (68) | 53 (71) | 11 (61) | |
| Mean years (CI) | 29.75 (27.2–22.3) | 60.6 (55.3–66.0) | < 0.0001 | 40.5 (29.6–51.3) |
| Days after 2nd vac. (mean, CI) | n.a. | 13 (12.1–13.9) | n.a. | |
| Days after infection (mean, CI) | 53 (48.7–57.1) | n.a. | < 0.0001* | n.a. |
| Date of sample | 11/2020–3/2021 | 01/2021–04-2021 | 02-2021 |
n.a. = not applicable * days after 2nd vaccination compared with days after first symptoms of infection,